CVRdatabase
Menu

BOOST Pharma ApS

Private limited companyCVR 41120495FrederiksbergActive

BOOST Pharma ApS is a private limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2020. Equity was negative at the end of 2025 (−DKK 11.9m). The company made a loss in both 2024 and 2025, most recently DKK 9.2m. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 7.6m−244.6% vs. 2024
Net profit−DKK 9.2m−117% vs. 2024
Equity−DKK 11.9m−68.3% vs. 2024
Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 4.3m to DKK 9.2m (2024 → 2025).

Employees

  • 3 more employees than a year earlier: 4 (07/2026) against 1 (07/2025).

Management and owners, last 24 months

  • New in management: Hans Thalsgård Schambye (ceo, 16/02/2026) and Hans Thalsgård Schambye (board member, 22/08/2025).
  • Stepped down: Ingelise Saunders (chair of the board, 17/06/2026), Lars Magnus Reinhold Westgren (board member, 17/06/2026) and John Öhd (board member, 17/06/2026) (+3).
  • New owners registered: BOOST Pharma AB (30/10/2025), Lilian Karin Florence Walter Jallow (05/11/2024) and Anna Cecilia Götherström (05/11/2024) (+2).
  • No longer registered as owner: Lilian Karin Florence Walter Jallow (04/11/2024), Anna Cecilia Götherström (04/11/2024) and Westknow AB (30/10/2025) (+4).

Registrations, last 24 months

  • 05/02/2026: Moved to Nordre Fasanvej 215, 2000 Frederiksberg
  • 05/03/2025: Share capital changed from 50,002 DKK to 55,002 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
  • 05/11/2024: Share capital changed from 44,002 DKK to 50,002 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0202020212022202320242025
EquityNet profit
Financial figures for BOOST Pharma ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−21−1,320−3,500−1,530−2,193−7,558−244.6%
Operating profit (EBIT)–−2,014−4,587−2,355−3,859−9,580−148.3%
Profit before tax−63−2,638−5,221−3,120−4,775−10,827−126.7%
Net profit−63−2,224−4,198−2,753−4,260−9,243−117%
Total assets3,6837,8234,3142,2177,6257,207−5.5%
Equity−23−2,248−6,446−9,199−7,040−11,851−68.3%
Liabilities3,70710,07110,76011,41514,66519,057+30%
Cash and cash equivalents3,6177,1093,2227587,0165,418−22.8%
Average number of employees–111220%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 11.9m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for BOOST Pharma ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202524/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202426/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202304/07/2024The companyPDFXBRL
202201/01/2022 – 31/12/202219/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202122/03/2022The companyPDFXBRL
202020/01/2020 – 31/12/202026/03/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
01234508/2109/2110/2111/2112/2101/2202/2203/2204/2205/2206/2207/2208/2209/2210/2211/2212/2201/2302/2303/2304/2305/2306/2307/2308/2309/2312/2407/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 7.6mNo. 380 of 421
Better than 10% of the companies in the industry
Equity−DKK 11.9mNo. 408 of 431
Better than 5% of the companies in the industry
Number of employees4No. 290 of 431
Better than 33% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,603of 69,742
Better than 0%
No. 69,649of 69,964
Better than 0%
Same industry and fewer than 20 employees329 companies in the comparison
No. 298of 323
Better than 8%
No. 316of 329
Better than 4%
Companies that are between 5 and 14 years old33,679 companies in the comparison
No. 33,464of 33,579
Better than 0%
No. 33,392of 33,678
Better than 1%
All companies of type ApS66,508 companies in the comparison
No. 66,251of 66,379
Better than 0%
No. 66,190of 66,505
Better than 0%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. BOOST Pharma ApS−DKK 7.6m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. BOOST Pharma ApS−DKK 9.2m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. BOOST Pharma ApS−DKK 11.9m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. BOOST Pharma ApS4
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • BOOST Pharma AB100%
BOOST Pharma ApS

Management

1 active registrations

Executive management

Executive management at BOOST Pharma ApS
NameRoleAppointed
Hans Thalsgård SchambyeCEO16/02/2026
Founders
Lilian Karin Florence Walter Jallow, Anna Cecilia Götherström, Lars Magnus Reinhold Westgren
Former management (13)
Former management at BOOST Pharma ApS
NameRoleAppointedResigned
Lilian Karin Florence Walter JallowDirector20/01/202009/02/2022
Anna Cecilia GötherströmDirector20/01/202001/05/2021
Lars Magnus Reinhold WestgrenDirector20/01/202001/05/2021
Ingelise SaundersChair of the board01/05/202117/06/2026
Lars Magnus Reinhold WestgrenBoard member01/05/202117/06/2026
Ingelise SaundersDirector09/02/202201/06/2024
Jonathan Jossi IlickiBoard member23/05/202425/06/2024
John ÖhdBoard member23/05/202417/06/2026
Everhardus Johannes Joseph KueppersDirector01/06/202430/09/2024
Jonas JendiBoard member25/06/202426/08/2024
Jonathan Jossi IlickiBoard member26/08/202417/06/2026
Ingelise SaundersCEO01/10/202416/02/2026
Hans Thalsgård SchambyeBoard member22/08/202517/06/2026

Signing rule: Selskabet tegnes af en direktør

Address and production units

1 active production units

Nordre Fasanvej 215
2000 Frederiksberg

Frederiksberg Municipality · Postcode 2000

Other companies at the address (8)

  • Sparrow Quantum ApSManufacture of computers and peripheral equipment
  • Adcendo ApSResearch and experimental development on natural sciences and engineering
  • Hemab ApSManufacture of pharmaceutical preparations
  • Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
  • Minervax ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
BOOST Pharma ApSNordre Fasanvej 215, 2000 Frederiksberg41025501841

Purpose

Selskabets formål er at forske, udvikle og tilvejebringe lægemidler.

The purpose is quoted from the register in Danish.

Changes year by year

58 registered events
20269 changesaccounts 1 · management 7 · address 1
  • Annual report for 2025 published
  • Hans Thalsgård Schambye stepped down as board member
  • Jonathan Jossi Ilicki stepped down as board member
  • John Öhd stepped down as board member
  • Lars Magnus Reinhold Westgren stepped down as board member
  • Ingelise Saunders stepped down as chair of the board
  • Hans Thalsgård Schambye appointed ceo
  • Ingelise Saunders stepped down as ceo
  • Moved to Nordre Fasanvej 215, 2000 Frederiksberg
202510 changesownership 6 · management 1 · accounts 1 · capital 1 · industry 1
  • BOOST Pharma AB registered as owner (100%)
  • Lilian Karin Florence Walter Jallow is no longer registered as owner
  • Anna Cecilia Götherström is no longer registered as owner
  • Stiftelsen Industrifonden is no longer registered as owner
  • Karolinska Development AB is no longer registered as owner
  • Westknow AB is no longer registered as owner
  • Hans Thalsgård Schambye appointed board member
  • Annual report for 2024 published
  • Share capital changed from 50,002 DKK to 55,002 DKK
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202420 changescapital 2 · ownership 7 · management 10 · accounts 1
  • Share capital changed from 44,002 DKK to 50,002 DKK
  • Lilian Karin Florence Walter Jallow registered as owner (20%)
  • Anna Cecilia Götherström registered as owner (20%)
  • Stiftelsen Industrifonden registered as owner (10%)
  • Karolinska Development AB registered as owner (10%)
  • Lilian Karin Florence Walter Jallow is no longer registered as owner
  • Anna Cecilia Götherström is no longer registered as owner
  • Ingelise Saunders appointed ceo
  • Everhardus Johannes Joseph Kueppers stepped down as director
  • Jonathan Jossi Ilicki appointed board member
  • Jonas Jendi stepped down as board member
  • Annual report for 2023 published
  • Jonas Jendi appointed board member
  • Jonathan Jossi Ilicki stepped down as board member
  • Everhardus Johannes Joseph Kueppers appointed director
  • Ingelise Saunders stepped down as director
  • Share capital changed from 40,002 DKK to 44,002 DKK
  • John Öhd appointed board member
  • Jonathan Jossi Ilicki appointed board member
  • SAUNDERS HOLDING ApS is no longer registered as owner
20231 changeaccounts 1
  • Annual report for 2022 published
20223 changesaccounts 1 · management 2
  • Annual report for 2021 published
  • Ingelise Saunders appointed director
  • Lilian Karin Florence Walter Jallow stepped down as director
20218 changesownership 3 · management 4 · accounts 1
  • Westknow AB registered as owner (20%)
  • Lars Magnus Reinhold Westgren is no longer registered as owner
  • Lars Magnus Reinhold Westgren appointed board member
  • Ingelise Saunders appointed chair of the board
  • Lars Magnus Reinhold Westgren stepped down as director
  • Anna Cecilia Götherström stepped down as director
  • Annual report for 2020 published
  • SAUNDERS HOLDING ApS registered as owner (5%)
20207 changesfounded 1 · management 3 · ownership 3
  • Registered as BOOST Pharma ApS
  • Lilian Karin Florence Walter Jallow appointed director
  • Lars Magnus Reinhold Westgren appointed director
  • Anna Cecilia Götherström appointed director
  • Lilian Karin Florence Walter Jallow registered as owner (25%)
  • Anna Cecilia Götherström registered as owner (25%)
  • Lars Magnus Reinhold Westgren registered as owner (25%)

Related companies

Same industry in Frederiksberg

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction